{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:18:43Z","timestamp":1722730723234},"reference-count":219,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cveq.2024.04.007","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T13:56:40Z","timestamp":1717855000000},"page":"307-339","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacologic Interventions to Immunologic and Immune-Mediated Conditions in Horses"],"prefix":"10.1016","volume":"40","author":[{"given":"Kelsey A.","family":"Hart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shune","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semdp.2012.08.005","article-title":"Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders","volume":"30","author":"Bagg","year":"2013","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"10.1016\/j.cveq.2024.04.007_bib2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/ph15091077","article-title":"Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases","volume":"15","author":"Ashraf","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib3","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1016\/j.jaci.2009.08.018","article-title":"Immunomodulator therapy: Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins","volume":"125","author":"Lee","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.cveq.2024.04.007_bib4","doi-asserted-by":"crossref","first-page":"113896","DOI":"10.1016\/j.addr.2021.113896","article-title":"Clinical translation of immunomodulatory therapeutics","volume":"176","author":"Nash","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0167-5699(93)90045-M","article-title":"Immunostimulants","volume":"14","author":"Hadden","year":"1993","journal-title":"Immunol Today"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.2042-3292.2001.tb01882.x","article-title":"Clinical use of immunomodulatory agents","volume":"13","author":"Rush","year":"2001","journal-title":"Equine Vet Educ"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0749-0739(17)30126-8","article-title":"Immunomodulation in horses","volume":"16","author":"Rush","year":"2000","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"11","key":"10.1016\/j.cveq.2024.04.007_bib10","first-page":"Cd013343","article-title":"Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease","volume":"11","author":"Fraser","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"3\u20134","key":"10.1016\/j.cveq.2024.04.007_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/S0100-736X1999000300001","article-title":"A\u00a0new concept in prophylaxis and therapy: paramunization by poxvirus inducers","volume":"19","author":"Mayr","year":"1999","journal-title":"Pesqui Vet Bras"},{"issue":"3\u20134","key":"10.1016\/j.cveq.2024.04.007_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-2427(94)05357-X","article-title":"Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs","volume":"46","author":"B\u00fcttner","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"issue":"10","key":"10.1016\/j.cveq.2024.04.007_bib13","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/1521-4141(200010)30:10<2962::AID-IMMU2962>3.0.CO;2-1","article-title":"Evidence for a Parapox ovis virus-associated superantigen","volume":"30","author":"Fachinger","year":"2000","journal-title":"Eur J Immunol"},{"issue":"17","key":"10.1016\/j.cveq.2024.04.007_bib14","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1128\/JVI.74.17.7943-7951.2000","article-title":"Poxvirus-induced immunostimulating effects on porcine leukocytes","volume":"74","author":"Fachinger","year":"2000","journal-title":"J\u00a0Virol"},{"issue":"17","key":"10.1016\/j.cveq.2024.04.007_bib15","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1128\/JVI.78.17.9400-9411.2004","article-title":"Immunomodulatory Effects of Inactivated Parapoxvirus Ovis (Orf Virus) on Human Peripheral Immune Cells: Induction of Cytokine Secretion in Monocytes and Th1-Like Cells","volume":"78","author":"Friebe","year":"2004","journal-title":"J\u00a0Virol"},{"issue":"18","key":"10.1016\/j.cveq.2024.04.007_bib16","doi-asserted-by":"crossref","first-page":"9411","DOI":"10.1128\/JVI.02362-08","article-title":"Conventional Bone Marrow-Derived Dendritic Cells Contribute to Toll-Like Receptor-Independent Production of Alpha\/Beta Interferon in Response to Inactivated Parapoxvirus ovis","volume":"83","author":"Siegemund","year":"2009","journal-title":"J\u00a0Virol"},{"issue":"3\u20134","key":"10.1016\/j.cveq.2024.04.007_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.vetmic.2009.01.035","article-title":"Inactivated Parapoxvirus ovis activates canine blood phagocytes and T lymphocytes","volume":"137","author":"Sch\u00fctze","year":"2009","journal-title":"Vet Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.cveq.2024.04.007_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01538831","article-title":"Highly attenuated poxviruses induce functional priming of neutrophils in\u00a0vitro","volume":"136","author":"F\u00f6rster","year":"1994","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.vetimm.2010.07.027","article-title":"Effects of two commercially available immunostimulants on leukocyte function of foals following ex\u00a0vivo exposure to Rhodococcus equi","volume":"138","author":"Ryan","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib20","article-title":"Equine PBMC Cytokines Profile after In\u00a0Vitro \u03b1- and \u03b3-EHV Infection: Efficacy of a Parapoxvirus ovis Based-Immunomodulator Treatment","volume":"5","author":"Hue","year":"2017","journal-title":"Vaccines (Basel)"},{"issue":"1\u20132","key":"10.1016\/j.cveq.2024.04.007_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2013.01.010","article-title":"A\u00a0systematic review of the immune-modulators Parapoxvirus ovis and Propionibacterium acnes for the prevention of respiratory disease and other infections in the horse","volume":"153","author":"Paillot","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u201310","key":"10.1016\/j.cveq.2024.04.007_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1439-0450.1997.tb01004.x","article-title":"The Use of Baypamun N in Crowding Associated Infectious Respiratory Disease: Efficacy of Baypamun N (Freeze Dried Product) in 4\u201310 Month Old Horses","volume":"44","author":"Ziebell","year":"1997","journal-title":"J\u00a0Vet Med - Ser B"},{"issue":"3\u20134","key":"10.1016\/j.cveq.2024.04.007_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.vetmic.2014.07.015","article-title":"Efficacy of a Parapoxvirus ovis-based immunomodulator against equine herpesvirus type 1 and Streptococcus equi equi infections in horses","volume":"173","author":"Ons","year":"2014","journal-title":"Vet Microbiol"},{"issue":"12","key":"10.1016\/j.cveq.2024.04.007_bib24","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3390\/vaccines10122139","article-title":"Immunostimulating Effect of Inactivated Parapoxvirus Ovis on the Serological Response to Equine Influenza Booster Vaccination","volume":"10","author":"Carnet","year":"2022","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.cveq.2024.04.007_bib27","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.4049\/jimmunol.174.7.4295","article-title":"Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes","volume":"174","author":"Kalis","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib28","doi-asserted-by":"crossref","first-page":"e39155","DOI":"10.1371\/journal.pone.0039155","article-title":"TLR9-dependent and independent pathways drive activation of the immune system by Propionibacterium acnes","volume":"7","author":"Tchaptchet","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib29","first-page":"1673","article-title":"The Distribution and Persistence in\u00a0vivo of Corynebacterium parvum in Relation to Its Antitumor Activity","volume":"37","author":"Scott","year":"1977","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.cveq.2024.04.007_bib30","doi-asserted-by":"crossref","first-page":"e29020","DOI":"10.1371\/journal.pone.0029020","article-title":"Intratumoral Injection of Propionibacterium acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses","volume":"6","author":"Tsuda","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0165-2427(98)00111-1","article-title":"Immunologic function in horses after non-specific immunostimulant administration","volume":"63","author":"Flaminio","year":"1998","journal-title":"Vet Immunol Immunopathol"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0737-0806(06)80132-2","article-title":"Adjunct treatment of equine respiratory disease complex (ERDC) with the Propionibacterium acnes immunostimulant, EqStim","volume":"10","author":"Vail","year":"1990","journal-title":"J\u00a0Equine Vet Sci"},{"issue":"1\u20132","key":"10.1016\/j.cveq.2024.04.007_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vetimm.2012.11.020","article-title":"The effect of an immunomodulator (Parapoxvirus ovis) on cell-mediated immunity (CMI) in abruptly weaned foals","volume":"153","author":"Adams","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0737-0806(96)80160-2","article-title":"Evaluation of an immunostimulant in preventing shipping stress related respiratory disease","volume":"16","author":"Nestved","year":"1996","journal-title":"J\u00a0Equine Vet Sci"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2460\/javma.231.1.107","article-title":"Effect of adjunctive treatment with intravenously administered Propionibacterium acnes on reproductive performance in mares with persistent endometritis","volume":"231","author":"Rohrbach","year":"2007","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/glycob\/8.2.113","article-title":"Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects","volume":"8","author":"Chatterjee","year":"1998","journal-title":"Glycobiology"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2958.2004.04183.x","article-title":"Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response","volume":"53","author":"Briken","year":"2004","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imr.12263","article-title":"Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus","volume":"264","author":"Stamm","year":"2015","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1096-2867(97)80032-1","article-title":"Immunotherapy and cytokines","volume":"12","author":"Van Kampen","year":"1997","journal-title":"Semin Vet Med Surg Small Anim"},{"issue":"1\u20132","key":"10.1016\/j.cveq.2024.04.007_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.vetimm.2007.04.009","article-title":"Immune parameters in mares resistant and susceptible to persistent post-breeding endometritis: effects of immunomodulation","volume":"118","author":"Fumuso","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.cveq.2024.04.007_bib42","doi-asserted-by":"crossref","first-page":"624094","DOI":"10.3389\/fcimb.2021.624094","article-title":"Interferons: Tug of War Between Bacteria and Their Host","volume":"11","author":"Alphonse","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"10.1016\/j.cveq.2024.04.007_bib43","first-page":"1","article-title":"Clinical study evaluating a purified mycobacterial cell wall extract for the treatment of equine respiratory disease","volume":"13","author":"Cormack","year":"1991","journal-title":"Equine Pract"},{"issue":"1\u20132","key":"10.1016\/j.cveq.2024.04.007_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-2427(03)00137-5","article-title":"Endometrial IL-1beta, IL-6 and TNF-alpha, mRNA expression in mares resistant or susceptible to post-breeding endometritis. Effects of estrous cycle, artificial insemination and immunomodulation","volume":"96","author":"Fumuso","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jevs.2007.01.010","article-title":"Use of a Mycobacterial Cell Wall Extract (MCWE) in Susceptible Mares to Clear Experimentally Induced Endometritis With Streptococcus zooepidemicus","volume":"27","author":"Rogan","year":"2007","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2024.04.007_bib46","doi-asserted-by":"crossref","first-page":"103102","DOI":"10.1016\/j.jevs.2020.103102","article-title":"Evaluation of Locally Injected Mycobacterium Cell Wall Fraction in Horses with Sarcoids","volume":"90","author":"Caston","year":"2020","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2024.04.007_bib47","doi-asserted-by":"crossref","first-page":"635800","DOI":"10.3389\/fvets.2021.635800","article-title":"Mycobacterial Cell Wall Stimulant in the Treatment of Squamous Cell Carcinoma: A Case Series Regarding Treatment in Equine, Bovine and Caprine Patients","volume":"8","author":"Halleran","year":"2021","journal-title":"Front Vet Sci"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/0253-7613.161249","article-title":"Imiquimod - Its role in the treatment of cutaneous malignancies","volume":"47","author":"Bubna","year":"2015","journal-title":"Indian J Pharmacol"},{"issue":"13","key":"10.1016\/j.cveq.2024.04.007_bib52","first-page":"3528","article-title":"Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine","volume":"52","author":"Sidky","year":"1992","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jir.1994.14.81","article-title":"Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in\u00a0vitro","volume":"14","author":"Weeks","year":"1994","journal-title":"J\u00a0Interferon Res"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib54","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1084\/jem.20070021","article-title":"Tumoricidal activity of TLR7\/8-activated inflammatory dendritic cells","volume":"204","author":"Stary","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-3164.2009.00877.x","article-title":"The efficacy of imiquimod 5% cream (Aldara\u00ae) in the treatment of aural plaque in horses: a pilot open-label clinical trial","volume":"21","author":"Torres","year":"2010","journal-title":"Vet Dermatol"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12305","article-title":"Imiquimod treatment for Equus caballus papillomavirus infection in equine aural plaques","volume":"27","author":"Zakia","year":"2016","journal-title":"Vet Dermatol"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-3164.2006.00526.x","article-title":"Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study","volume":"17","author":"Nogueira","year":"2006","journal-title":"Vet Dermatol"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib58","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/vde.12900","article-title":"Topical treatment of equine sarcoids with imiquimod 5% cream or Sanguinaria canadensis and zinc chloride \u2013 an open prospective study","volume":"31","author":"Pettersson","year":"2020","journal-title":"Vet Dermatol"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2460\/javma.249.3.311","article-title":"Treatment of sarcoids in equids: 230 cases (2008\u20132013)","volume":"249","author":"Haspeslagh","year":"2016","journal-title":"J\u00a0Am Vet Med Assoc"},{"year":"2022","series-title":"Cellular and molecular immunology","author":"Abbas","key":"10.1016\/j.cveq.2024.04.007_bib60"},{"issue":"12","key":"10.1016\/j.cveq.2024.04.007_bib61","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib62","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral Actions of Interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.coviro.2011.11.001","article-title":"Induction and function of type I and III interferon in response to viral infection","volume":"1","author":"Levy","year":"2011","journal-title":"Current Opinion in Virology"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00169-11","article-title":"Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection","volume":"2","author":"Mack","year":"2011","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-3083.1984.tb00988.x","article-title":"Effects of Interferon-alpha\/beta and Interferon-gamma Preparations on Phagocytosis by Mouse Peritoneal Macrophages","volume":"20","author":"Rollag","year":"1984","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib66","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2011.03412.x","article-title":"Regulation of effector and memory T-cell functions by type I interferon","volume":"132","author":"Huber","year":"2011","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.cveq.2024.04.007_bib67","first-page":"594","article-title":"Treatment of inflammatory airway disease in young standardbreds with interferon alpha","volume":"45","author":"Moore","year":"2004","journal-title":"Can Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib68","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jvim.13824","article-title":"Inflammatory Airway Disease of Horses--Revised Consensus Statement","volume":"30","author":"Couetil","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1294\/jes.19.91","article-title":"Effect of low-dose human interferon-alpha on shipping fever of Thoroughbred racehorses","volume":"19","author":"Akai","year":"2008","journal-title":"J Equine Sci"},{"issue":"12","key":"10.1016\/j.cveq.2024.04.007_bib70","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2460\/ajvr.1990.51.12.2006","article-title":"Effects of human alpha interferon on experimentally induced equine herpesvirus-1 infection in horses","volume":"51","author":"Seahorn","year":"1990","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib71","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11096-005-1319-7","article-title":"Side effects of interferon-\u03b1 therapy","volume":"27","author":"Sleijfer","year":"2005","journal-title":"Pharm World Sci"},{"issue":"31","key":"10.1016\/j.cveq.2024.04.007_bib72","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1073\/pnas.0404328101","article-title":"Critical role for granulocyte colony-stimulating factor in inflammatory arthritis","volume":"101","author":"Lawlor","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.cveq.2024.04.007_bib73","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ncprheum0291","article-title":"Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease","volume":"2","author":"Eyles","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM199207023270106","article-title":"Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts)","volume":"327","author":"Lieschke","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tvjl.2006.08.001","article-title":"Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine","volume":"174","author":"Fern\u00e1ndez-Var\u00f3n","year":"2007","journal-title":"Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00134-003-2049-8","article-title":"Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients?","volume":"30","author":"Azoulay","year":"2004","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib77","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199207093270207","article-title":"Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (second of two parts)","volume":"327","author":"Lieschke","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib78","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc10031","article-title":"Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis","volume":"15","author":"Bo","year":"2011","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1542\/peds.105.2.392","article-title":"Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor","volume":"105","author":"Calhoun","year":"2000","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib80","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.2042-3306.1994.tb04392.x","article-title":"Haematological, bone marrow and clinical chemical changes in neonatal foals given canine recombinant granulocyte-colony stimulating factor","volume":"26","author":"Zinkl","year":"1994","journal-title":"Equine Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib81","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.2042-3306.1994.tb04359.x","article-title":"Preliminary studies of recombinant bovine granulocyte-colony stimulating factor on haematological values in normal neonatal foals","volume":"26","author":"Madigan","year":"1994","journal-title":"Equine Vet J"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2746\/042516403775600497","article-title":"Neonatal neutropenia in an Arabian foal","volume":"35","author":"Davis","year":"2010","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1040638711416850","article-title":"Alloimmune neonatal neutropenia and neonatal isoerythrolysis in a Thoroughbred colt","volume":"24","author":"Wong","year":"2012","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib84","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1532-950X.1993.tb00410.x","article-title":"Effects of perioperative granulocyte colony-stimulating factor on horses with ascending colonic ischemia","volume":"22","author":"Sullivan","year":"1993","journal-title":"Vet Surg"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cveq.2016.11.008","article-title":"Corticosteroids and Immune Suppressive Therapies in Horses","volume":"33","author":"Leclere","year":"2017","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.cveq.2024.04.007_bib87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vetimm.2016.11.003","article-title":"The effect of free and carrier-bound cortisol on equine neutrophil function","volume":"183","author":"Fratto","year":"2017","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib88","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-018-1360-0","article-title":"Cortisol modulates inflammatory responses in LPS-stimulated RAW264.7 cells via the NF-\u03baB and MAPK pathways","volume":"14","author":"Dong","year":"2018","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.cveq.2024.04.007_bib89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.intimp.2018.01.021","article-title":"Cortisol inhibits NF-\u03baB and MAPK pathways in LPS activated bovine endometrial epithelial cells","volume":"56","author":"Dong","year":"2018","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.cveq.2024.04.007_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune Effects of Corticosteroids in Sepsis. Mini Review","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib91","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib92","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0090-6980(82)90085-5","article-title":"Evidence that prednisolone is inhibitory to the cyclooxygenase activity of human rectal mucosa","volume":"23","author":"Hawkey","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1016\/j.cveq.2024.04.007_bib93","series-title":"Mechanism of inhibition of prostaglandin biosynthesis by anti-inflammatory steroids","first-page":"261","author":"Di Rosa","year":"1980"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib94","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jvim.15411","article-title":"Retrospective evaluation of clinical outcome after chemotherapy for lymphoma in 15 equids (1991-2017)","volume":"33","author":"Luethy","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib95","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of Infectious Complications in Patients Taking Glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib96","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2746\/042516408X333399","article-title":"Experimental reactivation of equine herpesvirus-3 following corticosteroid treatment","volume":"40","author":"Barrandeguy","year":"2008","journal-title":"Equine Vet J"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib97","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1939-1676.2010.0554.x","article-title":"Molecular investigation of the viral kinetics of equine herpesvirus-1 in blood and nasal secretions of horses after corticosteroid-induced recrudescence of latent infection","volume":"24","author":"Pusterla","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib98","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/gut.37.5.613","article-title":"Corticosteroids reduce regenerative repair of epithelium in experimental gastric ulcers","volume":"37","author":"Carpani De Kaski","year":"1995","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cveq.2024.04.007_bib99","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40264-018-0645-3","article-title":"Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case\u2013Control Analysis Based on Swiss Claims Data","volume":"41","author":"Reinau","year":"2018","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/apt.13298","article-title":"Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study","volume":"42","author":"Tseng","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.cveq.2024.04.007_bib101","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2460\/ajvr.1999.60.08.977","article-title":"Gastric hemorrhage in dogs given high doses of methylprednisolone sodium succinate","volume":"60","author":"Rohrer","year":"1999","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2024.04.007_bib102","first-page":"69","article-title":"Equine glandular gastric disease: prevalence, impact and management strategies","volume":"10","author":"Banse","year":"2019","journal-title":"Vet Med Res Rep"},{"key":"10.1016\/j.cveq.2024.04.007_bib103","article-title":"Intra-articular triamcinolone acetonide injection results in increases in systemic insulin and glucose concentrations in horses without insulin dysregulation","author":"Boger","year":"2023","journal-title":"Equine Vet J"},{"issue":"7","key":"10.1016\/j.cveq.2024.04.007_bib104","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2460\/ajvr.68.7.753","article-title":"Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses","volume":"68","author":"Tiley","year":"2007","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib105","first-page":"617","article-title":"Diagnostic evaluation of insulin and glucose dynamics in light-breed horses receiving dexamethasone","volume":"63","author":"Timko","year":"2022","journal-title":"Can Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2746\/042516409X475779","article-title":"Equine laminitis: Induced by 48h hyperinsulinaemia in Standardbred horses","volume":"42","author":"De Laat","year":"2010","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib107","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tvjl.2011.07.007","article-title":"Continuous intravenous infusion of glucose induces endogenous hyperinsulinaemia and lamellar histopathology in Standardbred horses","volume":"191","author":"De Laat","year":"2012","journal-title":"Vet J"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib108","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2460\/javma.253.4.470","article-title":"Case-control study of risk factors for pasture-and endocrinopathy-associated laminitis in North American horses","volume":"253","author":"Coleman","year":"2018","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.04.007_bib109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prevetmed.2016.11.012","article-title":"Disease and pharmacologic risk factors for first and subsequent episodes of equine laminitis: A cohort study of free-text electronic medical records","volume":"136","author":"Welsh","year":"2017","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.cveq.2024.04.007_bib110","unstructured":"Frank N., Bailey S.R., Bertin F.-R., et al., Recommendations for the Diagnosis and Management of Equine Metabolic Syndrome (EMS). In: Equine Endocrinology Group, 2022. Available at: https:\/\/sites.tufts.edu\/equineendogroup\/files\/2022\/10\/EMS-EEG-Recommendations-2022.pdf. Accessed May 27, 2024."},{"issue":"1\u20133","key":"10.1016\/j.cveq.2024.04.007_bib111","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2741\/1249","article-title":"Pharmacologic immunosuppression","volume":"9","author":"Barshes","year":"2004","journal-title":"Front Biosci"},{"issue":"8","key":"10.1016\/j.cveq.2024.04.007_bib112","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2009.11.001","article-title":"Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: A novel mechanism of AZA\/6-MP","volume":"218","author":"Aldinucci","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib114","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/evj.13384","article-title":"Immune-mediated haemolytic anaemia and thrombocytopenia in 25 adult equids: 1997-2016","volume":"53","author":"Easton-Jones","year":"2021","journal-title":"Equine Vet J"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-3164.2004.00423.x","article-title":"Pemphigus foliaceus in the horse: a retrospective study of 20 cases","volume":"15","author":"Vandenabeele","year":"2004","journal-title":"Vet Dermatol"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib116","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12002","article-title":"Pemphigus vulgaris in a Welsh pony stallion: case report and demonstration of antidesmoglein autoantibodies","volume":"24","author":"Winfield","year":"2013","journal-title":"Vet Dermatol"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib117","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2460\/javma.2004.224.83","article-title":"Flow cytometric detection of platelet-bound antibody in three horses with immune-mediated thrombocytopenia","volume":"224","author":"McGurrin","year":"2004","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib118","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2460\/javma.1991.199.05.591","article-title":"Azathioprine for treatment of immune-mediated thrombocytopenia in two horses","volume":"199","author":"Humber","year":"1991","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"10","key":"10.1016\/j.cveq.2024.04.007_bib119","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.2042-3292.2010.00109.x","article-title":"Successful treatment of presumptive immune mediated thrombocytopenia and dermatitis with azathioprine in a pregnant mare","volume":"22","author":"Hardefeldt","year":"2010","journal-title":"Equine Vet Educ"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/eve.12116","article-title":"Septic funiculitis caused by Streptococcus equi subspecies equi infection with associated immune-mediated haemolytic anaemia","volume":"26","author":"Caniglia","year":"2014","journal-title":"Equine Vet Educ"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/vr.159.1.13","article-title":"Idiopathic immune-mediated polysynovitis in three horses","volume":"159","author":"Pusterla","year":"2006","journal-title":"Vet Rec"},{"issue":"9","key":"10.1016\/j.cveq.2024.04.007_bib122","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2460\/ajvr.2005.66.1578","article-title":"Pharmacokinetics of azathioprine following single-dose intravenous and oral administration and effects of azathioprine following chronic oral administration in horses","volume":"66","author":"White","year":"2005","journal-title":"Am J Vet Res"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib124","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1939-1676.2000.tb02266.x","article-title":"Thiopurine Methyltransferase in Red Blood Cells of Dogs, Cats, and Horses","volume":"14","author":"White","year":"2000","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00498470","article-title":"Directed biosynthesis of Cyclosporins","volume":"14","author":"Kobel","year":"1982","journal-title":"Eur J Appl Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02737887","article-title":"Calcineurin","volume":"30","author":"Hemenway","year":"1999","journal-title":"Cell Biochem Biophys"},{"year":"2023","series-title":"Cyclosporine. StatPearls. StatPearls Publishing Copyright \u00a9 2023","author":"Tapia","key":"10.1016\/j.cveq.2024.04.007_bib127"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"issue":"20","key":"10.1016\/j.cveq.2024.04.007_bib129","doi-asserted-by":"crossref","first-page":"12378","DOI":"10.1074\/jbc.273.20.12378","article-title":"T\u00a0Lymphocyte Activation Signals for Interleukin-2 Production Involve Activation of MKK6-p38 and MKK7-SAPK\/JNK Signaling Pathways Sensitive to Cyclosporin A","volume":"273","author":"Matsuda","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"6380","key":"10.1016\/j.cveq.2024.04.007_bib130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/357695a0","article-title":"Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation","volume":"357","author":"Clipstone","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib131","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2567.2003.01585.x","article-title":"Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets","volume":"108","author":"Tajima","year":"2003","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib132","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/08923970701812746","article-title":"Cyclosporin A Up-regulates B7-DC Expression on Dendritic Cells in an IL-4-dependent Manner In\u00a0Vitro, Which is Associated with Decreased Allostimulatory Capacity of Dendritic Cells","volume":"30","author":"Geng","year":"2008","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib133","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4049\/jimmunol.178.5.3107","article-title":"Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells","volume":"178","author":"Goodridge","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib134","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2003-07-2412","article-title":"Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cveq.2024.04.007_bib135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1208\/s12248-011-9259-8","article-title":"The immunosuppressive activity of polymeric micellar formulation of cyclosporine A: in\u00a0vitro and in\u00a0vivo studies","volume":"13","author":"Hamdy","year":"2011","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib136","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4067\/S0716-97602010000300010","article-title":"Cyclosporin A-treated dendritic cells may affect the outcome of organ transplantation by decreasing CD4+ CD25+ regulatory T\u00a0cell proliferation","volume":"43","author":"Pino-Lagos","year":"2010","journal-title":"Biol Res"},{"issue":"7","key":"10.1016\/j.cveq.2024.04.007_bib137","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.transproceed.2003.09.020","article-title":"Cyclosporine preconditions dendritic cells during differentiation and reduces IL-2 and IL-12 production following activation: a potential tolerogenic effect","volume":"35","author":"Sauma","year":"2003","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib138","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaci.2016.02.026","article-title":"Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients","volume":"138","author":"Imbert","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.cveq.2024.04.007_bib139","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/AAC.38.12.2883","article-title":"In\u00a0vitro and ex\u00a0vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus","volume":"38","author":"Roilides","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib140","first-page":"754","article-title":"The transcription factor nuclear factor of activated T\u00a0cells c3 modulates the function of macrophages in sepsis","volume":"6","author":"Ranjan","year":"2014","journal-title":"J\u00a0Innate Immun"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib141","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vop.12368","article-title":"Episcleral cyclosporine A implants for the management of unilateral keratoconjunctivitis sicca in an 8-year-old mare","volume":"20","author":"Mackenzie","year":"2017","journal-title":"Vet Ophthalmol"},{"issue":"8","key":"10.1016\/j.cveq.2024.04.007_bib142","doi-asserted-by":"crossref","DOI":"10.1111\/eve.13589","article-title":"Outcome of superficial keratectomy without conjunctival graft as a surgical technique for immune-mediated keratitis in horses: Four cases","volume":"34","author":"Dieterman","year":"2022","journal-title":"Equine Vet Educ"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib143","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.3390\/ijms24065735","article-title":"PLDLA\/TPU Matrix Enriched with Cyclosporine A as a Therapeutic Platform for Immune-Mediated Keratitis (IMMK) in Horses","volume":"24","author":"Padjasek","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib144","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1463-5224.2010.00807.x","article-title":"Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis","volume":"13","author":"Gilger","year":"2010","journal-title":"Vet Ophthalmol"},{"issue":"s1","key":"10.1016\/j.cveq.2024.04.007_bib145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/vop.12185","article-title":"Retrospective evaluation of phacoemulsification and aspiration in 41 horses (46 eyes): visual outcomes vs. age, intraocular lens, and uveitis status","volume":"17","author":"Edelmann","year":"2014","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cveq.2024.04.007_bib146","first-page":"237","article-title":"Immunosuppressive Therapy","author":"Felippe","year":"2016","journal-title":"Equine Clinical Immunology"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib147","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cveq.2003.08.006","article-title":"Treatment of endotoxemia","volume":"19","author":"Moore","year":"2003","journal-title":"Vet Clin N Am Equine Pract"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib148","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cveq.2014.04.003","article-title":"Is it the systemic inflammatory response syndrome or endotoxemia in horses with colic?","volume":"30","author":"Moore","year":"2014","journal-title":"Vet Clin Equine Pract"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvp.12329","article-title":"Treatment of endotoxaemia and septicaemia in the equine patient","volume":"40","author":"Werners","year":"2017","journal-title":"J\u00a0Vet Pharmacol Therapeut"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2746\/0425164054529418","article-title":"Endotoxaemia: a review with implications for the horse","volume":"37","author":"Werners","year":"2005","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib151","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/vec.12271","article-title":"The use of nonsteroidal anti-inflammatory drugs in critically ill horses","volume":"25","author":"Cook","year":"2015","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cveq.2016.11.001","article-title":"Nonsteroidal anti-inflammatory drug use in horses","volume":"33","author":"Knych","year":"2017","journal-title":"Vet Clin N Am Equine Pract"},{"issue":"10","key":"10.1016\/j.cveq.2024.04.007_bib153","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/ani13101597","article-title":"The clinical pharmacology and therapeutic evaluation of non-steroidal anti-inflammatory drugs in adult horses","volume":"13","author":"Mercer","year":"2023","journal-title":"Animals"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib154","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00432-022-04187-8","article-title":"Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention","volume":"149","author":"Ozleyen","year":"2023","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib155","first-page":"81","article-title":"Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J\u00a0Pharm Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib156","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jvp.13076","article-title":"Pharmacokinetics of grapiprant and effects on TNF-alpha concentrations following oral administration to horses","volume":"45","author":"Hoffmann","year":"2022","journal-title":"J\u00a0Vet Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib157","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2478\/pjvs-2014-0030","article-title":"Pharmacological characteristics of metamizole","volume":"17","author":"Jasiecka","year":"2014","journal-title":"Pol J Vet Sci"},{"issue":"3\u20134","key":"10.1016\/j.cveq.2024.04.007_bib158","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF02001915","article-title":"A\u00a0study of the mechanism of action of the mild analgesic dipyrone","volume":"41","author":"Shimada","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.cveq.2024.04.007_bib159","doi-asserted-by":"crossref","first-page":"580289","DOI":"10.3389\/fphar.2020.580289","article-title":"Analgesic effect of acetaminophen: a review of known and novel mechanisms of action","volume":"11","author":"Ohashi","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-6-10","article-title":"Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stress","volume":"6","author":"Tripathy","year":"2009","journal-title":"J\u00a0Neuroinflammation"},{"issue":"9","key":"10.1016\/j.cveq.2024.04.007_bib161","first-page":"1514","article-title":"Endotoxin-induced hemodynamic changes in ponies: effects of flunixin meglumine","volume":"42","author":"Bottoms","year":"1981","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib162","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.2042-3306.1981.tb04122.x","article-title":"Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony","volume":"13","author":"Moore","year":"1981","journal-title":"Equine Vet J"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib163","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1152\/jappl.1985.59.5.1464","article-title":"Effects of flunixin meglumine on cardiopulmonary responses to endotoxin in ponies","volume":"59","author":"Olson","year":"1985","journal-title":"J\u00a0Appl Physiol"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib164","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/evj.13013","article-title":"Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction","volume":"51","author":"Ziegler","year":"2019","journal-title":"Equine Vet J"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/evj.12224","article-title":"Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions","volume":"46","author":"Naylor","year":"2014","journal-title":"Equine Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib166","first-page":"138","article-title":"Comparison of the effects of ketoprofen and flunixin meglumine on the in\u00a0vitro response of equine peripheral blood monocytes to bacterial endotoxin","volume":"58","author":"Jackman","year":"1994","journal-title":"Can J Vet Res"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib167","first-page":"110","article-title":"Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor","volume":"47","author":"Moore","year":"1986","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib168","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-015-0427-4","article-title":"Evaluation of the efficacy of meloxicam for post-operative management of pain and inflammation in horses after orthopaedic surgery in a placebo controlled clinical field trial","volume":"11","author":"Walliser","year":"2015","journal-title":"BMC Vet Res"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib169","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/jvp.12461","article-title":"Postoperative pharmacokinetics of meloxicam in horses after surgery for colic syndrome","volume":"41","author":"Di Salvo","year":"2018","journal-title":"J\u00a0Vet Pharmacol Therapeut"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2460\/ajvr.68.6.614","article-title":"Effects of the cyclooxygenase inhibitor meloxicam on recovery of ischemia-injured equine jejunum","volume":"68","author":"Little","year":"2007","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib171","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2460\/ajvr.80.3.294","article-title":"Randomized blinded controlled trial of dipyrone as a treatment for pyrexia in horses","volume":"80","author":"Morresey","year":"2019","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib172","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jvim.16663","article-title":"Pharmacokinetics and efficacy of orally administered acetaminophen (paracetamol) in adult horses with experimentally induced endotoxemia","volume":"37","author":"Mercer","year":"2023","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib173","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/jvim.16093","article-title":"Effects of phenylbutazone alone or in combination with a nutritional therapeutic on gastric ulcers, intestinal permeability, and fecal microbiota in horses","volume":"35","author":"Whitfield-Cargile","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"issue":"8","key":"10.1016\/j.cveq.2024.04.007_bib174","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2460\/ajvr.70.8.992","article-title":"Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum","volume":"70","author":"Cook","year":"2009","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2746\/0425164054406865","article-title":"Effects of cyclooxygenase inhibitors flunixin and deracoxib on permeability of ischaemic-injured equine jejunum","volume":"37","author":"Tomlinson","year":"2005","journal-title":"Equine Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib176","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/eve.12454","article-title":"Nonsteroidal anti-inflammatory drug associated right dorsal colitis in the horse","volume":"29","author":"Davis","year":"2017","journal-title":"Equine Vet Educ"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib177","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/j.1552-4604.1995.tb04050.x","article-title":"Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis","volume":"35","author":"Schafer","year":"1995","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib178","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2460\/ajvr.68.3.251","article-title":"Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs","volume":"68","author":"Brainard","year":"2007","journal-title":"Am J Vet Res"},{"issue":"11","key":"10.1016\/j.cveq.2024.04.007_bib179","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2460\/ajvr.1997.58.11.1291","article-title":"Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses","volume":"58","author":"Baskett","year":"1997","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/CJ9.0000000000000111","article-title":"Is it time to restrict the clinical use of dipyrone?","volume":"47","author":"G\u00f3mez-Duarte","year":"2019","journal-title":"Colombian Journal of Anestesiology"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib181","doi-asserted-by":"crossref","first-page":"e0122918","DOI":"10.1371\/journal.pone.0122918","article-title":"Metamizole-Associated Adverse Events: A Systematic Review and Meta-Analysis","volume":"10","author":"K\u00f6tter","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cveq.2024.04.007_bib183","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/17425255.2023.2259787","article-title":"Advances in the understanding of acetaminophen toxicity mechanisms: a clinical toxicology perspective","volume":"19","author":"Chiew","year":"2023","journal-title":"Expet Opin Drug Metabol Toxicol"},{"year":"2023","series-title":"Lidocaine. StatPearls. StatPearls Publishing Copyright \u00a9 2023","author":"Beecham","key":"10.1016\/j.cveq.2024.04.007_bib184"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00003246-200003000-00025","article-title":"Effects of lidocaine administration on hemodynamics and cytokine responses to endotoxemia in rabbits","volume":"28","author":"Taniguchi","year":"2000","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib186","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1939-1676.2010.0555.x","article-title":"Effects of Lidocaine Infusion during Experimental Endotoxemia in Horses","volume":"24","author":"Peir\u00f3","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib187","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1213\/ANE.0000000000000360","article-title":"Intravenous lidocaine decreases tumor necrosis factor alpha expression both locally and systemically in pigs undergoing lung resection surgery","volume":"119","author":"Garutti","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cveq.2024.04.007_bib188","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/570370","article-title":"The protective effect of lidocaine on septic rats via the inhibition of high mobility group box 1 expression and NF-B activation","volume":"2013","author":"Wang","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.cveq.2024.04.007_bib189","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molimm.2018.03.010","article-title":"Nebulized lidocaine ameliorates allergic airway inflammation via downregulation of TLR2","volume":"97","author":"Wang","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cveq.2024.04.007_bib190","doi-asserted-by":"crossref","first-page":"102660","DOI":"10.1016\/j.amsu.2021.102660","article-title":"Systemic lidocaine administration influences NF-k\u03b2 gene expression, NF-k\u03b2 and TNF-\u03b1 protein levels on BALB\/c mice with musculoskeletal injury","volume":"69","author":"Karnina","year":"2021","journal-title":"Annals of Medicine and Surgery"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib191","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3892\/mmr.2013.1799","article-title":"Lidocaine protects against renal and hepatic dysfunction in septic rats via downregulation of Toll-like receptor 4","volume":"9","author":"Liu","year":"2014","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib192","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood.V56.2.203.203","article-title":"Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites","volume":"56","author":"MacGregor","year":"1980","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib193","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4049\/jimmunol.1301363","article-title":"Lidocaine reduces neutrophil recruitment by abolishing chemokine-induced arrest and transendothelial migration in septic patients","volume":"192","author":"Berger","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib194","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00000542-197402000-00009","article-title":"Local anesthetic inhibition of phagocytosis and metabolism of human leukocytes","volume":"40","author":"Cullen","year":"1974","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib195","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1189\/jlb.0305169","article-title":"Local anesthetics inhibit priming of neutrophils by lipopolysaccharide for enhanced release of superoxide: suppression of cytochrome b558 expression by disparate mechanisms","volume":"78","author":"Jinnouchi","year":"2005","journal-title":"J\u00a0Leukoc Biol"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib196","first-page":"736","article-title":"Intravenous lidocaine and small-intestinal size, abdominal fluid, and outcome after colic surgery in horses","volume":"16","author":"Brianceau","year":"2002","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib197","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1532-950X.2005.00113.x","article-title":"Intravenous continuous infusion of lidocaine for treatment of equine ileus","volume":"35","author":"Malone","year":"2006","journal-title":"Vet Surg"},{"issue":"2","key":"10.1016\/j.cveq.2024.04.007_bib198","first-page":"116","article-title":"A\u00a0CONSORT-guided, randomized, double-blind, controlled pilot clinical trial of inhaled lidocaine for the treatment of equine asthma","volume":"86","author":"Mahalingam-Dhingra","year":"2022","journal-title":"Can J Vet Res"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib199","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2885.2006.00797.x","article-title":"The disposition of lidocaine during a 12-hour intravenous infusion to postoperative horses","volume":"29","author":"Milligan","year":"2006","journal-title":"J\u00a0Vet Pharmacol Therapeut"},{"key":"10.1016\/j.cveq.2024.04.007_bib200","first-page":"245","article-title":"Review of the analgesic, prokinetic and anti- inflammatory uses of lidocaine","volume":"53","author":"Mudge","year":"2007","journal-title":"AAEP Proc Surg Lameness"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib201","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2885.2011.01356.x","article-title":"Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses","volume":"35","author":"Waxman","year":"2012","journal-title":"J\u00a0Vet Pharmacol Therapeut"},{"key":"10.1016\/j.cveq.2024.04.007_bib202","doi-asserted-by":"crossref","first-page":"984108","DOI":"10.3389\/fvets.2022.984108","article-title":"Clinical effects and pharmacokinetics of nebulized lidocaine in healthy horses","volume":"9","author":"Minuto","year":"2022","journal-title":"Front Vet Sci"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib203","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.cveq.2024.04.007_bib204","doi-asserted-by":"crossref","DOI":"10.1177\/08850666231183396","article-title":"Sepsis and adrenal insufficiency","author":"Fowler","year":"2023","journal-title":"J\u00a0Intensive Care Med"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib205","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1939-1676.2009.0323.x","article-title":"Hypothalamic-pituitary-adrenal axis dysfunction in hospitalized neonatal foals","volume":"23","author":"Hart","year":"2009","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib206","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jvim.15620","article-title":"Cortisol and adrenocorticotropic hormone concentrations in horses with systemic inflammatory response syndrome","volume":"33","author":"Stewart","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib207","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1203\/PDR.0b013e31821b502b","article-title":"Effects of low-dose hydrocortisone therapy on immune function in neonatal horses","volume":"70","author":"Hart","year":"2011","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.cveq.2024.04.007_bib208","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/ajcn\/34.9.1906","article-title":"Ascorbate-mediated stimulation of neutrophil motility and lymphocyte transformation by inhibition of the peroxidase\/H2O2\/halide system in\u00a0vitro and in\u00a0vivo","volume":"34","author":"Anderson","year":"1981","journal-title":"Am J Clin Nutr"},{"issue":"19","key":"10.1016\/j.cveq.2024.04.007_bib209","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1093\/nar\/gkac941","article-title":"Vitamin C enhances NF-\u03baB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells","volume":"50","author":"Morante-Palacios","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.cveq.2024.04.007_bib210","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/nu10111762","article-title":"Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of Sepsis. Focus on Ascorbic Acid","volume":"10","author":"Marik","year":"2018","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.cveq.2024.04.007_bib211","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1515\/cclm-2017-0054","article-title":"Vitamin B1 in critically ill patients: needs and challenges","volume":"55","author":"Collie","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"10.1016\/j.cveq.2024.04.007_bib212","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.freeradbiomed.2010.02.031","article-title":"Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages","volume":"48","author":"Yadav","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.cveq.2024.04.007_bib213","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.chest.2017.07.014","article-title":"Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction","volume":"152","author":"Barabutis","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib214","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-1131-2","article-title":"Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?","volume":"19","author":"Carr","year":"2015","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib215","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF00262893","article-title":"Thiamine deficiency in the critically ill","volume":"14","author":"Cruickshank","year":"1988","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib216","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jcrc.2010.03.003","article-title":"Thiamine deficiency in critically ill patients with sepsis","volume":"25","author":"Donnino","year":"2010","journal-title":"J\u00a0Crit Care"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib217","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00003246-199603000-00006","article-title":"Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk","volume":"24","author":"Borrelli","year":"1996","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.cveq.2024.04.007_bib218","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/01.CCM.0000172548.34622.DE","article-title":"Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle","volume":"33","author":"Tyml","year":"2005","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.cveq.2024.04.007_bib219","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jvim.16188","article-title":"Blood thiamine (vitamin B1), ascorbic acid (vitamin C), and cortisol concentrations in healthy and ill neonatal foals","volume":"35","author":"Wong","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.chest.2020.02.049","article-title":"Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: The ORANGES Trial","volume":"158","author":"Iglesias","year":"2020","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib221","first-page":"1236","article-title":"Efficacy of ascorbic acid, thiamine, and hydrocortisone combination therapy: meta-analysis of randomized controlled trials","volume":"37","author":"Kato","year":"2023","journal-title":"In\u00a0Vivo"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib222","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/jvim.15896","article-title":"Effects of administration of ascorbic acid and low-dose hydrocortisone after infusion of sublethal doses of lipopolysaccharide to horses","volume":"34","author":"Anderson","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"year":"2021","series-title":"Effects of thiamine, vitamin C, and hydrocortisone treatment on oxidative stress in healthy neonatal foals. Oral abstract at the 27th Annual International Veterinary Emergency and Critical Care Symposium","author":"Macy","key":"10.1016\/j.cveq.2024.04.007_bib223"},{"key":"10.1016\/j.cveq.2024.04.007_bib224","doi-asserted-by":"crossref","DOI":"10.1111\/jvim.16934","article-title":"Effect of intravenous administration of ascorbic acid (vitamin C) on oxidative status in healthy adult horses","author":"Taylor","year":"2024","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib225","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-021-02599-1","article-title":"High dose intravenous vitamin C treatment in Sepsis: associations with acute kidney injury and mortality","volume":"22","author":"McCune","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.cveq.2024.04.007_bib226","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-023-03806-8","article-title":"Randomized trial to assess the potential role of ascorbic acid and statin for post-contrast acute kidney injury prevention","author":"Hashem","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.cveq.2024.04.007_bib227","doi-asserted-by":"crossref","first-page":"121875","DOI":"10.1016\/j.lfs.2023.121875","article-title":"A\u00a0new treatment approach: Melatonin and ascorbic acid synergy shields against sepsis-induced heart and kidney damage in male rats","volume":"329","author":"\u00dcst\u00fcnda\u011f","year":"2023","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.cveq.2024.04.007_bib229","doi-asserted-by":"crossref","first-page":"8","DOI":"10.17085\/apm.20089","article-title":"Perioperative glucocorticoid management based on current evidence","volume":"16","author":"Seo","year":"2021","journal-title":"Anesthesia and Pain Medicine"},{"issue":"6","key":"10.1016\/j.cveq.2024.04.007_bib230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids","volume":"63","author":"Williams","year":"2018","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.cveq.2024.04.007_bib231","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2746\/042516402776186056","article-title":"Prednisone per os is likely to have limited efficacy in horses","volume":"34","author":"Peroni","year":"2010","journal-title":"Equine Vet J"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073924000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073924000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T03:13:52Z","timestamp":1722654832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073924000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":219,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0749073924000336"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2024.04.007","relation":{},"ISSN":["0749-0739"],"issn-type":[{"type":"print","value":"0749-0739"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Interventions to Immunologic and Immune-Mediated Conditions in Horses","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2024.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}